Back to Journals » Psoriasis: Targets and Therapy » Volume 3 » default
ESCI
Impact Factor
Psoriasis: Targets and Therapy
ISSN: 2230-326X
- View all (141)
- Volume 14, 2024 (8)
- Volume 13, 2023 (7)
- Volume 12, 2022 (22)
- Volume 11, 2021 (14)
- Volume 10, 2020 (8)
- Volume 9, 2019 (13)
- Volume 8, 2018 (12)
- Volume 7, 2017 (9)
- Volume 6, 2016 (15)
- Volume 5, 2015 (13)
- Volume 4, 2014 (5)
- Volume 3, 2013 (4)
- Volume 2, 2012 (10)
- Volume 1, 2011 (1)
Archive: Volume 3, 2013
Original Research
Reanalysis of microarray data reveals insights into altered transcriptional activity of T helper 17 and regulatory T cell signaling in psoriasis
Kotb I, Meharg C, Barker RN, Ormerod A
Psoriasis: Targets and Therapy 2013, 3:31-47
Published Date: 12 December 2013
Review
Biologic therapy and tuberculosis: our experience and review of literature
Fabroni C, D'Erme AM, Lotti T
Psoriasis: Targets and Therapy 2013, 3:25-29
Published Date: 3 July 2013
Review
Epidemiology, genetics and management of psoriatic arthritis 2013: focus on developments of who develops the disease, its clinical features, and emerging treatment options
Haroon M, FitzGerald O, Winchester R
Psoriasis: Targets and Therapy 2013, 3:11-23
Published Date: 12 April 2013
Review
Role of T-cell-mediated inflammation in psoriasis: pathogenesis and targeted therapy
Flatz L, Conrad C
Psoriasis: Targets and Therapy 2013, 3:1-10
Published Date: 27 February 2013